2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid

C28H30ClN9O8 — CID 162533509

IUPAC2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid
SMILESC[C@@]1(O)[C@@H](COC(Cc2ccc(-c3ccccc3C(=O)O)cc2)(C(=O)O)C2NNNN2)O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@@H]1O
InChIInChI=1S/C28H30ClN9O8/c1-27(44)17(46-22(19(27)39)38-12-31-18-20(30)32-26(29)33-21(18)38)11-45-28(25(42)43,24-34-36-37-35-24)10-13-6-8-14(9-7-13)15-4-2-3-5-16(15)23(40)41/h2-9,12,17,19,22,24,34-37,39,44H,10-11H2,1H3,(H,40,41)(H,42,43)(H2,30,32,33)/t17-,19+,22-,27-,28?/m1/s1
InChIKeyRSGZPBINFGITDM-IXHRALMFSA-N
MW656.06 g/mol
LogP-0.04
Rot. Bonds10

About 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid

2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid (PubChem CID 162533509) has the molecular formula C28H30ClN9O8 and a molecular weight of 656.06 g/mol. Its IUPAC name is 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid.

Molecular Properties

Compound Name2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid
PubChem CID162533509
Molecular FormulaC28H30ClN9O8
Molecular Weight656.06 g/mol
Exact Mass655.19
IUPAC Name2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid
SMILESC[C@@]1(O)[C@@H](COC(Cc2ccc(-c3ccccc3C(=O)O)cc2)(C(=O)O)C2NNNN2)O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@@H]1O
InChIInChI=1S/C28H30ClN9O8/c1-27(44)17(46-22(19(27)39)38-12-31-18-20(30)32-26(29)33-21(18)38)11-45-28(25(42)43,24-34-36-37-35-24)10-13-6-8-14(9-7-13)15-4-2-3-5-16(15)23(40)41/h2-9,12,17,19,22,24,34-37,39,44H,10-11H2,1H3,(H,40,41)(H,42,43)(H2,30,32,33)/t17-,19+,22-,27-,28?/m1/s1
InChIKeyRSGZPBINFGITDM-IXHRALMFSA-N
XLogP-0.04
TPSA251.26 Ų
H-Bond Donors9
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms46
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500656.06
LogP ≤ 5-0.04
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1015

Analyze 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid?
The IUPAC name of 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid (CID 162533509) is 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid.
What is the SMILES notation for 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid?
The canonical SMILES for 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid is C[C@@]1(O)[C@@H](COC(Cc2ccc(-c3ccccc3C(=O)O)cc2)(C(=O)O)C2NNNN2)O[C@@H](n2cnc3c(N)nc(Cl)nc32)[C@@H]1O.
What is the InChIKey of 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid?
The InChIKey is RSGZPBINFGITDM-IXHRALMFSA-N. The full InChI is InChI=1S/C28H30ClN9O8/c1-27(44)17(46-22(19(27)39)38-12-31-18-20(30)32-26(29)33-21(18)38)11-45-28(25(42)43,24-34-36-37-35-24)10-13-6-8-14(9-7-13)15-4-2-3-5-16(15)23(40)41/h2-9,12,17,19,22,24,34-37,39,44H,10-11H2,1H3,(H,40,41)(H,42,43)(H2,30,32,33)/t17-,19+,22-,27-,28?/m1/s1.
What are the key properties of 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid?
2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid has a molecular weight of 656.06 g/mol, XLogP of -0.04, 10 rotatable bonds, 9 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[2-[[(2R,3S,4R,5R)-5-(6-amino-2-chloropurin-9-yl)-3,4-dihydroxy-3-methyloxolan-2-yl]methoxy]-2-carboxy-2-(tetrazolidin-5-yl)ethyl]phenyl]benzoic acid is sourced from PubChem (CID 162533509), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).